(Q40792696)

23 September 2017

Mechanisms of immune escape in central nervous system infection with neurotropic JC virus variant (English)

1 reference

evasion of host immune response

23 September 2017

1 reference

based on heuristic

inferred from title

infection of the central nervous system

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26874214%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Mireia Sospedra

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26874214%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Roland Martin

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26874214%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

2

Ilijas Jelcic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26874214%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

1

Ivan Jelcic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26874214%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

3

Christian Kempf

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26874214%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

6

Sven Schippling

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26874214%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

author name string

Fabienne Largey

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26874214%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Herbert Budka

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26874214%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

publication date

13 February 2016

1 reference

23 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26874214%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

volume

79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26874214%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26874214%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

page(s)

404-418

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26874214%20AND%20SRC:MED&resulttype=core&format=json

Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies

13 June 2020

cites work

1 reference

Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis

21 January 2018

1 reference

Progressive multifocal leukoencephalopathy: why gray and white matter

21 January 2018

1 reference

JC virus granule cell neuronopathy: A novel clinical syndrome distinct from progressive multifocal leukoencephalopathy

21 January 2018

1 reference

Productive infection of cerebellar granule cell neurons by JC virus in an HIV+ individual

21 January 2018

1 reference

JC virus granule cell neuronopathy is associated with VP1 C terminus mutants

21 January 2018

1 reference

Progressive multifocal leukoencephalopathy (PML) development is associated with mutations in JC virus capsid protein VP1 that change its receptor specificity

21 January 2018

1 reference

Immune reconstitution inflammatory syndrome in natalizumab-associated PML.

21 January 2018

1 reference

Disease course and outcome of 15 monocentrically treated natalizumab-associated progressive multifocal leukoencephalopathy patients

21 January 2018

1 reference

JC virus persistence following progressive multifocal leukoencephalopathy in multiple sclerosis patients treated with natalizumab

21 January 2018

1 reference

Immunology of progressive multifocal leukoencephalopathy.

21 January 2018

1 reference

A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.

21 January 2018

1 reference

Role of CD4+ and CD8+ T-cell responses against JC virus in the outcome of patients with progressive multifocal leukoencephalopathy (PML) and PML with immune reconstitution inflammatory syndrome

21 January 2018

1 reference

Characterization of lymphocytic infiltrates in progressive multifocal leukoencephalopathy: co-localization of CD8(+) T cells with JCV-infected glial cells

21 January 2018

1 reference

In situ evidence of JC virus control by CD8+ T cells in PML-IRIS during HIV infection

21 January 2018

1 reference

Central role of JC virus-specific CD4+ lymphocytes in progressive multi-focal leucoencephalopathy-immune reconstitution inflammatory syndrome.

21 January 2018

1 reference

TCR bias and HLA cross-restriction are strategies of human brain-infiltrating JC virus-specific CD4+ T cells during viral infection.

21 January 2018

1 reference

Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors

21 January 2018

1 reference

Progressive multifocal leukoencephalopathy in persons infected with human immunodeficiency virus, San Francisco, 1981-1989.

21 January 2018

1 reference

T cell epitope mapping of JC polyoma virus-encoded proteome reveals reduced T cell responses in HLA-DRB1*04:01+ donors

21 January 2018

1 reference

JC polyomavirus infection is strongly controlled by human leucocyte antigen class II variants

21 January 2018

1 reference

JC virus granule cell neuronopathy and GCN-IRIS under natalizumab treatment

21 January 2018

1 reference

SV40 vectors carrying minimal sequence of viral origin with exchangeable capsids.

21 January 2018

1 reference

Activation of CD8 T cells induces expression of CD4, which functions as a chemotactic receptor.

21 January 2018

1 reference

Potent HIV-specific responses are enriched in a unique subset of CD8+ T cells that coexpresses CD4 on its surface

21 January 2018

1 reference

The CD4 molecule on CD8+ T lymphocytes directly enhances the immune response to viral and cellular antigens

21 January 2018

1 reference

Peripheral CD4(+)CD8(+) T cells are differentiated effector memory cells with antiviral functions.

21 January 2018

1 reference

Gone over to the dark side: Natalizumab-associated JC virus infection of neurons in cerebellar gray matter

21 January 2018

1 reference

JCV GCN in a natalizumab-treated MS patient is associated with mutations of the VP1 capsid gene

21 January 2018

1 reference

Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy

21 January 2018

1 reference

JC polyomavirus granule cell neuronopathy in a patient treated with rituximab

21 January 2018

1 reference

Frequent infection of cerebellar granule cell neurons by polyomavirus JC in progressive multifocal leukoencephalopathy

21 January 2018

1 reference

Neurons as targets for T cells in the nervous system.

21 January 2018

1 reference

Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology

21 January 2018

1 reference

CD4 T cell responses in latent and chronic viral infections

21 January 2018

1 reference

Revealing the role of CD4(+) T cells in viral immunity

21 January 2018

1 reference

Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ANA.24574

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26874214%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

1 reference